Omeros (OMER) Liabilities and Shareholders Equity (2010 - 2026)

Omeros' (OMER) quarterly Liabilities and Shareholders Equity came in at $286.2 million in Q1 2026, up 21.69% year-on-year from $235.2 million in Q1 2025, and down 12.12% quarter-over-quarter from $325.6 million in Q4 2025.

Omeros (OMER) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Omeros has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $286.2 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $286.2 million, up 21.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $998.1 million (down 15.55% YoY), and the FY2025 annual result was $325.6 million, up 17.52% from the prior year.
  • Liabilities and Shareholders Equity came in at $286.2 million for Q1 2026 at Omeros, down from $325.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $591.0 million in Q4 2022 to a low of $185.7 million in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $356.3 million (2024), against an average of $372.9 million.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 270.7% in 2022 and sank 46.25% in 2025, its largest moves.
  • Omeros' Liabilities and Shareholders Equity stood at $591.0 million in 2022, then slumped by 35.99% to $378.3 million in 2023, then dropped by 26.75% to $277.1 million in 2024, then advanced by 17.52% to $325.6 million in 2025, then retreated by 12.12% to $286.2 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $286.2 million (Q1 2026), $325.6 million (Q4 2025), and $185.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn 286.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 286.17 Mn
Dec 31, 2025 325.63 Mn
Sep 30, 2025 185.71 Mn
Jun 30, 2025 200.57 Mn
Mar 31, 2025 235.16 Mn
Dec 31, 2024 277.08 Mn
Sep 30, 2024 313.34 Mn
Jun 30, 2024 356.31 Mn
Mar 31, 2024 437.49 Mn
Dec 31, 2023 378.27 Mn
Sep 30, 2023 493.07 Mn
Jun 30, 2023 527.42 Mn
Mar 31, 2023 560.13 Mn
Dec 31, 2022 590.97 Mn
Sep 30, 2022 457.55 Mn
Jun 30, 2022 345.64 Mn
Mar 31, 2022 369.26 Mn
Dec 31, 2021 419.27 Mn
Sep 30, 2021 123.43 Mn
Jun 30, 2021 145.39 Mn